Purdue Pharma sentenced to $5.5B in opioid criminal case
Fox Business • • nation
Key Points:
- Purdue Pharma was sentenced to pay $5.5 billion for its role in the opioid epidemic, following its 2020 guilty plea for deceiving federal regulators and paying kickbacks to doctors to boost opioid sales.
- The company was fined $3.544 billion in connection with bankruptcy proceedings and ordered to pay an additional $2 billion in criminal forfeiture.
- U.S. District Judge Madeline Cox Arleo required Purdue's Chairman Steve Miller to apologize to opioid victims, who testified extensively about the company's impact during the sentencing hearing.
- Purdue Pharma acknowledged responsibility and expressed regret, while the judge criticized government authorities for failing to regulate the company effectively.
- Purdue Pharma will cease operations by May 1, 2026, with its assets transferring to a new entity, Knoa Pharma LLC, which will continue distributing its medicines.
